{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-346678","form_type":"8-K","ticker":"TWST","cik":"0001581280","company_name":"Twist Bioscience Corp","filed_at":"2021-12-02T23:59:59+00:00","discovered_at":"2026-05-14T18:04:13.140759+00:00","generated_at":"2026-06-28T04:09:43.509954+00:00","sec_items":["8.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"low","headline":"Twist Bioscience completes acquisition of Abveris (AbX Biologics)","bullets":["Acquisition closed December 1, 2021, under merger agreement dated November 19, 2021.","Twist issued stock consideration; entered Registration Rights Agreement to register resale of those shares.","No financial terms (deal value, premium, or expected impact) disclosed in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-346678","json":"https://secwatch.observer/filing/0001193125-21-346678.json","markdown":"https://secwatch.observer/filing/0001193125-21-346678.md","text":"https://secwatch.observer/filing/0001193125-21-346678.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1581280/000119312521346678/0001193125-21-346678-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1581280/000119312521346678/d150633d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T04:09:43.509954+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}